However, Bium et al. [60] obtained opposite results in their analysis of KRAS mutation characteristics in 26 mCRC patients, finding a certain consistency between the detection rates of KRAS mutations in CTCs and paired CRC tissues, independent of the clinical and pathological characteristics of CRC patients. The gene discussed is KRAS; the disease is colorectal carcinoma.